Chemoinformaics analysis of (1R,2R,5S)-2,6,6-TRIMETHYLBICYCLO[3.1.1]HEPTAN-2-OL
| Molecular Weight | 154.253 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 24 |
| Exact Molecular Weight | 154.136 | nRing | 3 |
| Solubility: LogS | -3.265 | nHRing | 0 |
| Solubility: LogP | 4.436 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 29.5043 |
| nHD | 1 | BPOL | 18.0577 |
| QED | 0.177 |
| Synth | 4.013 |
| Natural Product Likeliness | 1.967 |
| NR-PPAR-gamma | 0.875 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.172 |
| Pgp-sub | 0.043 |
| HIA | 0.594 |
| CACO-2 | -6.335 |
| MDCK | 0.00000708 |
| BBB | 0.002 |
| PPB | 0.950917 |
| VDSS | 0.428 |
| FU | 0.0469636 |
| CYP1A2-inh | 0.04 |
| CYP1A2-sub | 0.858 |
| CYP2c19-inh | 0.039 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.619 |
| CYP2c9-sub | 0.663 |
| CYP2d6-inh | 0.027 |
| CYP2d6-sub | 0.21 |
| CYP3a4-inh | 0.077 |
| CYP3a4-sub | 0.346 |
| CL | 10.49 |
| T12 | 0.72 |
| hERG | 0.102 |
| Ames | 0.129 |
| ROA | 0.206 |
| SkinSen | 0.959 |
| Carcinogencity | 0.027 |
| EI | 0.902 |
| Respiratory | 0.028 |
| NR-Aromatase | 0.651 |
| Antiviral | No |
| Prediction | 0.934817 |